Javascript must be enabled to continue!
Analysis of the gut microbiome of Japanese inflammatory bowel disease patients
View through CrossRef
Abstract
Background
Gut microbiome dysbiosis has been reported in patients with inflammatory bowel disease (IBD). However, gut microbiome of healthy Japanese individuals differs from that of other populations and gut microbiome of Japanese IBD patients has not been well characterized. We conducted a cross-sectional study to characterize the gut microbiome of Japanese patients with Crohn’s disease (CD) and ulcerative colitis (UC).
Methods
Two-hundred and eighty-four IBD patients (39 CD patients and 245 UC patients) and 31 healthy participants were enrolled. Gut microbiome was analyzed by 16S rRNA amplicon sequencing using Illumina Miseq.
Results
Significant differences were observed among the gut microbiome of CD patients, UC patients and healthy individuals. Species richness and evenness were significantly lower in patients with active IBD than in healthy individuals. At the genus level, Bifidobacterium was most abundant genera in all three groups. Pathogenic obligate anaerobes such as Prevotella and Veillonella were increased and commensal bacteria such as Ruminococcus was decreased in IBD patients compared with healthy individuals.
Conclusions
CD patients and UC patients showed unique patterns of gut microbiome dysbiosis. Patients with active IBD had severe dysbiotic changes. However, characteristic features of the gut microbiome of Japanese individuals, such as high abundance of the genus Bifidobacterium, were maintained in IBD patients.
Springer Science and Business Media LLC
Title: Analysis of the gut microbiome of Japanese inflammatory bowel disease patients
Description:
Abstract
Background
Gut microbiome dysbiosis has been reported in patients with inflammatory bowel disease (IBD).
However, gut microbiome of healthy Japanese individuals differs from that of other populations and gut microbiome of Japanese IBD patients has not been well characterized.
We conducted a cross-sectional study to characterize the gut microbiome of Japanese patients with Crohn’s disease (CD) and ulcerative colitis (UC).
Methods
Two-hundred and eighty-four IBD patients (39 CD patients and 245 UC patients) and 31 healthy participants were enrolled.
Gut microbiome was analyzed by 16S rRNA amplicon sequencing using Illumina Miseq.
Results
Significant differences were observed among the gut microbiome of CD patients, UC patients and healthy individuals.
Species richness and evenness were significantly lower in patients with active IBD than in healthy individuals.
At the genus level, Bifidobacterium was most abundant genera in all three groups.
Pathogenic obligate anaerobes such as Prevotella and Veillonella were increased and commensal bacteria such as Ruminococcus was decreased in IBD patients compared with healthy individuals.
Conclusions
CD patients and UC patients showed unique patterns of gut microbiome dysbiosis.
Patients with active IBD had severe dysbiotic changes.
However, characteristic features of the gut microbiome of Japanese individuals, such as high abundance of the genus Bifidobacterium, were maintained in IBD patients.
Related Results
Cardiac functions and aortic elasticity in children with inflammatory bowel disease: effect of age at disease onset
Cardiac functions and aortic elasticity in children with inflammatory bowel disease: effect of age at disease onset
AbstractAim:Childhood onset inflammatory bowel disease is more aggressive and has rapidly progressive clinical course than adult inflammatory bowel disease. Early-onset inflammator...
Risk factor analysis of enterocutaneous fistula after small bowel surgery
Risk factor analysis of enterocutaneous fistula after small bowel surgery
Abstract:
Background: ECF most frequently follows a complication of abdominal surgery, although a smaller number occur spontaneously in association with conditia
Background: Entero...
Gut Microbiome Alterations in COVID-19
Gut Microbiome Alterations in COVID-19
Abstract
Since the outset of the coronavirus disease 2019 (COVID-19) pandemic, the gut microbiome in COVID-19 has garnered substantial interest, given its significan...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Quantifying the impact of Human Leukocyte Antigen on the human gut microbiome
Quantifying the impact of Human Leukocyte Antigen on the human gut microbiome
AbstractObjectiveThe gut microbiome is affected by a number of factors, including the innate and adaptive immune system. The major histocompatibility complex (MHC), or the human le...
A hidden confounder for microbiome studies: medications used years before sample collection
A hidden confounder for microbiome studies: medications used years before sample collection
ABSTRACT
Medication usage is a known contributor to the inter-individual variability of the gut m...
Impact of urbanization on gut microbiome mosaics across geographic and dietary contexts
Impact of urbanization on gut microbiome mosaics across geographic and dietary contexts
ABSTRACT
This study provides a comprehensive assessment of how urban-rural divides influence gut microbial diversity and composit...
Zero to hero
Zero to hero
Western images of Japan tell a seemingly incongruous story of love, sex and marriage – one full of contradictions and conflicting moral codes. We sometimes hear intriguing stories ...

